Zealand Pharma A/S
(NASDAQ : ZEAL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. 0.85%93.831.9%$1163.93m
BMYBristol-Myers Squibb Co. 0.71%61.321.0%$1017.19m
JNJJohnson & Johnson 0.37%147.270.7%$1009.80m
PFEPfizer Inc. -0.22%35.930.9%$970.99m
MRKMerck & Co., Inc. 0.82%82.220.7%$859.42m
LLYEli Lilly & Co. -1.02%149.171.1%$531.64m
AZNAstraZeneca Plc -0.04%53.851.2%$283.65m
NVSNovartis AG 0.93%85.910.2%$152.29m
GSKGlaxoSmithKline Plc 0.11%41.700.2%$126.54m
NVONovo Nordisk A/S 0.23%64.490.1%$83.99m
SNYSanofi 0.30%50.100.2%$78.95m
RGENRepligen Corp. -1.28%120.267.1%$68.99m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.08%68.140.0%$52.90m
RETAReata Pharmaceuticals, Inc. -2.49%126.303.4%$37.91m
TPTXTurning Point Therapeutics, Inc. 1.28%62.980.0%$37.82m

Company Profile

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.